Education
About Us
Working with TipRanks
Follow Us
Outset Medical, Inc. (OM)
:OM
OM Stock Chart & Stats
$15.53
-$0.10(-9.09%)
At close: 4:00 PM EST
$15.53
-$0.10(-9.09%)
Day’s Range― - ―
52-Week Range$4.00 - $25.35
Previous CloseN/A
Volume1.92M
Average Volume (3M)660.62K
Market Cap
$79.60M
Enterprise Value$174.98M
Total Cash (Recent Filing)$178.64M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)―
Beta1.57
Next Earnings
Feb 17, 2026EPS Estimate
-0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding18,153,090
10 Day Avg. Volume520,122
30 Day Avg. Volume660,621
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio-0.49
Enterprise Value/Market Cap2.20
Enterprise Value/Revenue1.46
Enterprise Value/Gross Profit3.87
Enterprise Value/Ebitda-2.51
Forecast
1Y Price Target
$15.75Price Target Upside1.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost EfficiencyOperating expenses were down nearly 20% year over year, and the company used less than $6M of cash during Q3, indicating efficient cost management.
Product DifferentiationThe Tablo System is differentiated and offers a compelling value proposition, with Console revenue beating consensus expectations in Q3 and stable utilization.
Revenue GrowthConsole revenue has returned to growth and the deal pipeline was reportedly intact.
Bears Say
Revenue MissOutset Medical reported Q3 revenue of $29.4M, falling short of the consensus estimate of $30.7M.
Revenue OutlookOM lowered its FY25 revenue outlook to $115M-$120M to account for longer timing for a couple larger enterprise console deals slipping from Q4 into 2026 and potential disruption to the company's salesforce.
Sales DisruptionThe recent departure of OM's head of sales potentially resulting in some salesforce disruption during a crucial time.
Outset Medical News
OM FAQ
What was Outset Medical, Inc.’s price range in the past 12 months?
Outset Medical, Inc. lowest stock price was $4.00 and its highest was $25.35 in the past 12 months.
What is Outset Medical, Inc.’s market cap?
Outset Medical, Inc.’s market cap is $79.60M.
When is Outset Medical, Inc.’s upcoming earnings report date?
Outset Medical, Inc.’s upcoming earnings report date is Feb 17, 2026 which is in 65 days.
How were Outset Medical, Inc.’s earnings last quarter?
Outset Medical, Inc. released its earnings results on Nov 10, 2025. The company reported -$0.69 earnings per share for the quarter, missing the consensus estimate of -$0.655 by -$0.035.
Is Outset Medical, Inc. overvalued?
According to Wall Street analysts Outset Medical, Inc.’s price is currently Undervalued.
Does Outset Medical, Inc. pay dividends?
Outset Medical, Inc. does not currently pay dividends.
What is Outset Medical, Inc.’s EPS estimate?
Outset Medical, Inc.’s EPS estimate is -0.68.
How many shares outstanding does Outset Medical, Inc. have?
Outset Medical, Inc. has 18,153,090 shares outstanding.
What happened to Outset Medical, Inc.’s price movement after its last earnings report?
Outset Medical, Inc. reported an EPS of -$0.69 in its last earnings report, missing expectations of -$0.655. Following the earnings report the stock price went down -48.467%.
Which hedge fund is a major shareholder of Outset Medical, Inc.?
Currently, no hedge funds are holding shares in OM
Outset Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.75 (1.42% Upside)
$15.75 (1.42% Upside)
Blogger Sentiment
Bullish
OM Sentiment 70%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $19.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.40%
12-Months-Change
Fundamentals
Return on Equity
-92.33%
Trailing 12-Months
Asset Growth
-5.34%
Trailing 12-Months
Company Description
Outset Medical, Inc.
Outset Medical (OM) is a medical technology company focused on transforming the way dialysis is delivered to patients. The company operates within the healthcare sector, specifically targeting renal care, with a core product offering of the Tablo Hemodialysis System. This innovative system simplifies the dialysis process for both patients and healthcare providers, enabling efficient treatment in various settings, including in-home and clinic environments.
OM Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Outset Medical. While there were positives such as increased console sales, improved gross margins, and a strong cash position, the company faced challenges with revenue growth, leadership changes, and deal closing timing. The uncertainty about future sales leadership and the revision of revenue guidance contributed to a cautious outlook.View all OM earnings summariesOM Revenue Breakdown
47.04% Consoles
32.37% Consumables
20.59% Service and other revenue
OM Stock 12 Month Forecast
Average Price Target
$15.75
▲(1.42% Upside)
Technical Analysis
Ownership Overview
4.07% Insiders
31.58% Mutual Funds
33.63% Other Institutional Investors
21.81% Public Companies and
Individual Investors